What Is (R)-mevalonate:NAD+ oxidoreductase
Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.
Last updated: April 10, 2026
Key Facts
- Enzyme classification EC 1.1.1.33; belongs to the oxidoreductase family (EC class 1) that catalyzes oxidation-reduction reactions
- Catalyzes the NAD+-dependent oxidation of (R)-mevalonate to mevalonic semialdehyde, a direct intermediate in cholesterol biosynthesis pathway
- Found in eukaryotic cells (humans, plants, fungi); absent in bacteria which lack the mevalonate pathway for sterol synthesis
- Requires NAD+ as a cofactor; each enzyme molecule regenerates NADH, linking energy metabolism to steroid hormone and cholesterol production
- The mevalonate pathway accounts for approximately 90% of cellular cholesterol production; this enzyme's activity directly controls the rate-limiting steps of that synthesis
Overview
(R)-mevalonate:NAD+ oxidoreductase is a critical metabolic enzyme that catalyzes a fundamental step in the mevalonate pathway, one of the most important biochemical routes in eukaryotic cells. This enzyme, classified as EC 1.1.1.33 and commonly referred to as mevalonate dehydrogenase, performs an oxidative reaction that directly contributes to the biosynthesis of cholesterol, sex hormones, adrenal steroids, and other essential isoprenoid molecules.
The enzyme operates by catalyzing the oxidation of (R)-mevalonate into mevalonic semialdehyde, utilizing NAD+ (nicotinamide adenine dinucleotide) as an electron acceptor in the process. This reaction is reversible but biochemically favors the forward direction under physiological conditions. The mevalonate pathway processes approximately 200 grams of cholesterol daily in the human body, making enzymes like mevalonate dehydrogenase essential for maintaining proper cellular function, membrane integrity, and hormone production.
How It Works
The enzymatic mechanism of (R)-mevalonate:NAD+ oxidoreductase involves a series of coordinated steps that transfer electrons from the substrate to NAD+:
- Substrate Binding: (R)-mevalonate enters the enzyme's active site, positioning the hydroxyl groups for oxidation while NAD+ simultaneously binds to a nearby binding domain
- Electron Transfer: The enzyme catalyzes hydride (H-) transfer from the mevalonate substrate to the NAD+ molecule, oxidizing mevalonate while reducing NAD+ to NADH
- Product Release: Mevalonic semialdehyde is released from the enzyme active site, followed by NADH release, allowing NAD+ regeneration for subsequent catalytic cycles
- Cofactor Regeneration: The NADH produced is utilized in downstream metabolic processes or oxidized back to NAD+ through the electron transport chain, maintaining the NAD+/NADH ratio
- Catalytic Turnover: The enzyme achieves high catalytic efficiency with turnover numbers enabling rapid processing of mevalonate, supporting the high metabolic demand for cholesterol synthesis
Key Comparisons
| Aspect | (R)-mevalonate:NAD+ Oxidoreductase | Other Oxidoreductases |
|---|---|---|
| Substrate Specificity | Highly specific for (R)-mevalonate; NAD+-dependent only | Varies widely; some use NADP+, FAD, or other cofactors |
| Pathway Role | Second committed step in cholesterol biosynthesis (mevalonate pathway) | Functions across diverse metabolic pathways (glycolysis, TCA cycle, etc.) |
| Cellular Distribution | Located primarily in cytoplasm and microsomes of eukaryotic cells | Found across various cellular compartments (mitochondria, cytoplasm, peroxisomes) |
| Regulation | Feedback inhibited by downstream products (cholesterol); affected by sterol regulatory element binding proteins (SREBPs) | Regulation varies; many use allosteric regulation or covalent modification |
| Therapeutic Target | Not directly targeted; indirectly affected by statins and other cholesterol-lowering drugs | Some are major drug targets (HMG-CoA reductase, lactate dehydrogenase, etc.) |
Why It Matters
- Cholesterol Production: This enzyme directly controls cholesterol biosynthesis, affecting cellular membrane composition, fluidity, and structural integrity in all eukaryotic cells
- Hormone Synthesis: The mevalonate pathway, which depends on this enzyme's function, produces the isoprenoid precursors for all steroid hormones including testosterone, estrogen, and cortisol
- Metabolic Integration: By utilizing NAD+ as a cofactor, the enzyme links lipid biosynthesis to energy metabolism and the cellular redox state, allowing coordination of anabolic and catabolic processes
- Disease Implications: Dysregulation of mevalonate pathway enzymes is implicated in cardiovascular disease, cancer cell proliferation, and metabolic disorders affecting billions of people globally
- Drug Response: The activity of downstream mevalonate pathway enzymes influences how patients respond to statins and other lipid-lowering medications, with genetic variations affecting treatment efficacy
The mevalonate pathway represents one of the most conserved and essential biosynthetic routes in nature, and (R)-mevalonate:NAD+ oxidoreductase serves as a key regulatory checkpoint in this pathway. Understanding this enzyme's mechanism, regulation, and role in cellular metabolism has profound implications for understanding human health, aging, and the development of new therapeutic interventions targeting cholesterol-related diseases.